Novartis Current Ratio vs Asset Turnover Analysis

NVS Stock  USD 96.73  0.85  0.89%   
Novartis financial indicator trend analysis is infinitely more than just investigating Novartis AG ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novartis AG ADR is a good investment. Please check the relationship between Novartis Current Ratio and its Asset Turnover accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.

Current Ratio vs Asset Turnover

Current Ratio vs Asset Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novartis AG ADR Current Ratio account and Asset Turnover. At this time, the significance of the direction appears to have strong relationship.
The correlation between Novartis' Current Ratio and Asset Turnover is 0.64. Overlapping area represents the amount of variation of Current Ratio that can explain the historical movement of Asset Turnover in the same time period over historical financial statements of Novartis AG ADR, assuming nothing else is changed. The correlation between historical values of Novartis' Current Ratio and Asset Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Ratio of Novartis AG ADR are associated (or correlated) with its Asset Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Asset Turnover has no effect on the direction of Current Ratio i.e., Novartis' Current Ratio and Asset Turnover go up and down completely randomly.

Correlation Coefficient

0.64
Relationship DirectionPositive 
Relationship StrengthSignificant

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.

Asset Turnover

The ratio of net sales to average total assets, indicating how efficiently a company uses its assets to generate sales.
Most indicators from Novartis' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novartis AG ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Selling General Administrative is likely to gain to about 15 B in 2024. Discontinued Operations is likely to gain to about 5.5 B in 2024
 2021 2022 2023 2024 (projected)
Gross Profit37.0B36.3B34.2B32.3B
Total Revenue52.9B51.8B46.7B46.2B

Novartis fundamental ratios Correlations

0.710.660.780.920.780.520.710.920.920.290.97-0.280.120.7-0.07-0.26-0.010.890.77-0.050.00.880.430.410.55
0.710.850.880.390.180.170.90.450.630.580.630.290.420.38-0.4-0.470.180.910.64-0.15-0.530.940.220.50.73
0.660.850.960.360.180.040.70.390.740.610.50.070.60.26-0.42-0.520.390.740.680.16-0.660.860.270.750.61
0.780.880.960.50.360.110.750.520.830.580.66-0.030.460.4-0.36-0.470.210.840.740.15-0.50.940.340.660.77
0.920.390.360.50.90.650.430.990.830.070.92-0.46-0.050.710.12-0.08-0.080.660.65-0.060.310.620.420.260.28
0.780.180.180.360.90.460.280.840.76-0.120.84-0.63-0.340.710.290.09-0.320.530.590.060.480.480.450.020.23
0.520.170.040.110.650.460.120.690.350.170.55-0.36-0.120.230.10.01-0.260.330.12-0.210.330.260.230.04-0.07
0.710.90.70.750.430.280.120.490.610.170.70.220.160.45-0.25-0.370.140.90.68-0.14-0.40.880.110.230.62
0.920.450.390.520.990.840.690.490.820.110.92-0.380.00.70.07-0.13-0.050.70.65-0.120.240.650.410.270.27
0.920.630.740.830.830.760.350.610.820.290.88-0.410.110.65-0.12-0.31-0.010.790.760.14-0.10.840.590.430.49
0.290.580.610.580.07-0.120.170.170.110.290.110.250.650.02-0.45-0.370.130.380.17-0.07-0.460.480.280.710.5
0.970.630.50.660.920.840.550.70.920.880.11-0.33-0.130.740.02-0.17-0.20.870.71-0.10.150.820.460.160.49
-0.280.290.07-0.03-0.46-0.63-0.360.22-0.38-0.410.25-0.330.39-0.04-0.49-0.410.260.01-0.19-0.57-0.50.0-0.290.120.12
0.120.420.60.46-0.05-0.34-0.120.160.00.110.65-0.130.39-0.21-0.44-0.40.810.160.250.13-0.690.29-0.190.910.23
0.70.380.260.40.710.710.230.450.70.650.020.74-0.04-0.21-0.05-0.26-0.280.590.48-0.50.290.530.610.040.29
-0.07-0.4-0.42-0.360.120.290.1-0.250.07-0.12-0.450.02-0.49-0.44-0.050.96-0.06-0.2-0.090.110.72-0.28-0.25-0.35-0.27
-0.26-0.47-0.52-0.47-0.080.090.01-0.37-0.13-0.31-0.37-0.17-0.41-0.4-0.260.96-0.07-0.33-0.220.160.66-0.4-0.31-0.38-0.28
-0.010.180.390.21-0.08-0.32-0.260.14-0.05-0.010.13-0.20.260.81-0.28-0.06-0.07-0.020.250.22-0.50.08-0.420.67-0.06
0.890.910.740.840.660.530.330.90.70.790.380.870.010.160.59-0.2-0.33-0.020.7-0.14-0.250.970.320.350.68
0.770.640.680.740.650.590.120.680.650.760.170.71-0.190.250.48-0.09-0.220.250.70.19-0.160.750.270.470.53
-0.05-0.150.160.15-0.060.06-0.21-0.14-0.120.14-0.07-0.1-0.570.13-0.50.110.160.22-0.140.19-0.21-0.02-0.210.190.09
0.0-0.53-0.66-0.50.310.480.33-0.40.24-0.1-0.460.15-0.5-0.690.290.720.66-0.5-0.25-0.16-0.21-0.360.14-0.54-0.29
0.880.940.860.940.620.480.260.880.650.840.480.820.00.290.53-0.28-0.40.080.970.75-0.02-0.360.340.490.75
0.430.220.270.340.420.450.230.110.410.590.280.46-0.29-0.190.61-0.25-0.31-0.420.320.27-0.210.140.340.020.13
0.410.50.750.660.260.020.040.230.270.430.710.160.120.910.04-0.35-0.380.670.350.470.19-0.540.490.020.36
0.550.730.610.770.280.23-0.070.620.270.490.50.490.120.230.29-0.27-0.28-0.060.680.530.09-0.290.750.130.36
Click cells to compare fundamentals

Novartis Account Relationship Matchups

Novartis fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets118.4B132.1B131.8B117.5B99.9B103.1B
Short Long Term Debt Total29.3B38.0B31.1B28.0B26.3B18.6B
Other Current Liab15.4B17.5B18.0B17.2B15.1B11.4B
Total Current Liabilities28.3B33.1B30.2B28.7B26.4B22.0B
Total Stockholder Equity55.5B56.6B67.7B59.3B46.7B57.2B
Property Plant And Equipment Net13.7B13.9B13.1B12.2B10.9B13.5B
Current Deferred Revenue236M114M56M123M98M135.9M
Net Debt18.2B28.4B18.7B20.4B13.0B11.0B
Retained Earnings59.3B57.2B71.0B63.5B49.6B57.8B
Accounts Payable5.4B5.4B5.6B5.1B4.9B4.2B
Cash11.1B9.7B12.4B7.5B13.4B7.7B
Non Current Assets Total88.9B102.4B86.1B80.5B69.5B73.2B
Non Currrent Assets Other738M892M2.2B1.1B2.2B2.1B
Cash And Short Term Investments11.4B11.6B28.3B18.9B14.0B13.1B
Net Receivables8.6B8.5B8.3B8.3B9.4B8.8B
Common Stock Total Equity969M944M936M913M821.7M776.8M
Common Stock Shares Outstanding2.3B2.3B2.3B2.2B2.1B1.9B
Short Term Investments334M1.9B15.9B11.4B569M540.6M
Liabilities And Stockholders Equity118.4B132.1B131.8B117.5B99.9B103.1B
Non Current Liabilities Total34.6B42.3B33.8B29.4B26.8B23.6B
Inventory6.0B7.1B6.7B7.2B5.9B6.0B
Other Current Assets2.7B2.5B2.4B2.5B1.2B2.2B
Other Stockholder Equity(59.4B)(57.2B)(71.0B)(63.6B)(49.7B)(47.2B)
Total Liab62.8B75.4B64.0B58.0B53.2B45.6B
Property Plant And Equipment Gross13.7B13.9B13.1B12.2B22.8B14.0B
Total Current Assets29.5B29.7B45.7B36.9B30.5B29.9B
Short Term Debt7.3B10.1B6.6B6.2B6.3B6.3B
Common Stock936M913M901M890M825M767.6M
Accumulated Other Comprehensive Income54.6B55.7B66.8B58.5B45.9B52.6B
Intangible Assets28.8B36.8B34.2B31.6B26.9B22.4B
Other Liab12.5B14.4B9.2B7.6B8.7B8.5B
Other Assets14.8B14.7B12.4B4.8B5.6B10.1B
Long Term Debt20.4B26.3B22.9B20.2B18.4B12.8B
Good Will26.5B30.0B29.6B29.3B23.3B22.0B
Treasury Stock(69M)(80M)(53M)(48M)(55.2M)(58.0M)
Property Plant Equipment13.7B13.9B13.1B12.2B14.0B14.0B
Net Tangible Assets5.6B(5.5B)9.4B2.8B2.5B2.4B
Deferred Long Term Liab5.4B4.7B5.5B4.4B5.1B5.8B
Long Term Investments11.2B11.7B2.3B1.6B1.8B1.7B
Short Long Term Debt6.8B9.6B6.2B5.9B6.1B5.7B

Novartis Investors Sentiment

The influence of Novartis' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novartis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Novartis' public news can be used to forecast risks associated with an investment in Novartis. The trend in average sentiment can be used to explain how an investor holding Novartis can time the market purely based on public headlines and social activities around Novartis AG ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Novartis' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novartis' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novartis' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novartis.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novartis in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novartis' short interest history, or implied volatility extrapolated from Novartis options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Novartis AG ADR is a strong investment it is important to analyze Novartis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novartis' future performance. For an informed investment choice regarding Novartis Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novartis AG ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Complementary Tools for Novartis Stock analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.987
Dividend Share
3.919
Earnings Share
4.1
Revenue Per Share
22.467
Quarterly Revenue Growth
0.074
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.